Linalool showed potential in improving cognitive performance of Alzheimer’s disease models [45,46], with a mechanism potentially involving the decrease of acetylcholinesterase activity and an increased expression of brain-derived neurotrophic factor (BDNF) and the tropomyosin kinase B (TrkB) receptor [47]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.